Please assess the completion status of the following clinical trial:

Trial Title: Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Upper limb spasticity due to cerebral palsy~* Body weight 10 kg or over~* MAS score of 2 or more in affected elbow or wrist flexors~Exclusion Criteria:~* Fixed myocontracture~* Previous phenol or alcohol injection within 1 year~* Severe athetoid or dystonic movements~* Previous or planned surgery for spasticity in elbow or wrist flexors~* Neuromuscular disorders~* Previous Rhizotomy within 6 months~* Intrathecal baclofen within 30 days

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Group A (Type: EXPERIMENTAL): Group A - Treatments 1, 2, 3 and 4: Dysport 16 Units (U)/kg in one upper extremity (the study limb).
- Group B (Type: EXPERIMENTAL): Group B - Treatments 1, 2, 3 and 4: Dysport 8 U/kg in one upper extremity (the study limb).
- Group C (Type: EXPERIMENTAL): Group C - Treatment 1: Dysport 2 U/kg in one upper extremity (the study limb).~Group C - Treatments 2, 3 and 4: Dysport 8 or 16 U/kg in one upper extremity (the study limb).

Based on this trial design, predict the completion outcome and termination type (if applicable).